Causes of learning disability and epilepsy: A review

Current Opinion in Neurology

Volumn 24, Issue 2, 2011, Pages 154-158

  Prince, Elizabeth ^a   Ring, Howard ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Douglas House   (United Kingdom)

Author keywords

astrocytes; genome wide array comparative genomic hybridization; Rett syndrome

Indexed keywords

BUNGAROTOXIN RECEPTOR; CYCLIN DEPENDENT KINASE 5; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; METHYL CPG BINDING PROTEIN 2; NICOTINIC AGENT; NICOTINIC RECEPTOR ALPHA4;

ASTROCYTE; CELL FUNCTION; CHROMOSOME 15Q; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; EPILEPSY; FRAGILE X SYNDROME; GENE DELETION; GENERALIZED EPILEPSY; HUMAN; IDIOPATHIC DISEASE; LEARNING DISORDER; PATHOPHYSIOLOGY; PHENOTYPE; RETT SYNDROME; REVIEW;

ASTROCYTES; COMORBIDITY; DNA COPY NUMBER VARIATIONS; EPILEPSY; FRAGILE X SYNDROME; HUMANS; LEARNING DISORDERS; RETT SYNDROME;

EID: 79953066924     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3283444c70     Document Type: Review

References (33)

1. Mefford HC, Muhle H, Ostertag P, et al. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 2010;6:e1000962.
2. De Kovel CGF, Trucks H, Helbig I, et al. Recurrent microdeletionsat 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010;133:23-32.
3. Sharp AJ, Mefford HC, Li K, et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 2008;40:322-328. (Pubitemid 351311774)
4. Shinawi M, Schaaf CP, Bhatt SS, et al. A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet 2009;41:1269-1271.
5. Vendrame M, Maski KP, Chatterjee M, et al. Epilepsy in Prader-Willi syndrome: clinical characteristics and correlation to genotype. Epilepsy Behav 2010;19:306-310.
6. Orrico A, Zollino M, Galli L, et al. Late-onset Lennox-Gastaut syndrome in a patient with 15q11.2-q13. 1 duplication. Am J Med Genet A 2009;149A:1033-1035.
7. Yeung A, Bruno D, Scheffer IE, et al. 4.45 Mb microduplication in chromosome band 14q12 including FOXG1 in a girl with refractory epilepsy and intellectual impairment. Eur J Med Genet 2009;52:440-442.
8. Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23:185-188. (Pubitemid 29455390)
9. Nissenkorn A, Gak E, Vecksler M, et al. Epilepsy in Rett syndrome;the experience of a National Rett Center. Epilepsia 2010;51:1252-1258.
10. Glaze DG, Percy AK, Skinner S, et al. Epilepsy and the natural history of Rett syndrome. Neurology 2010;74:909-912.
11. Buoni S, Zannolli R, De Felice C, et al. EEG features and epilepsy in MECP2-mutated patients with the Zappella variant of Rett syndrome. Clin Neurophy-siol 2010;121:652-657.
12. Borroni B, Archetti S, Costanzi C, et al. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression. Neurobiol Aging 2009;30:1406-1412.
13. Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hip-pocampal function. Cell 2003;112:257-269. (Pubitemid 36144114)
14. Ho B-C, Andreasen NC, Dawson JD, Wassink TH. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry 2007;164:1890-1899. (Pubitemid 351739243)
15. Louhivuori V, Arvio M, Soronen P, et al. The Val66Met polymorphism in the BDNF gene is associated with epilepsy in fragile X syndrome. Epilepsy Res 2009;85:114-117.
16. Castren M, Gaily E,TengstromC, et al. Epilepsy caused by CDKL5 mutations. Eur J Paediatr Neurol 2011;15:65-69.
17. Elia M, Falco M, Ferri R, et al. CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy. Neurology 2008;71:997-999.
18. Sartori S, Rosa GD, Polli R, et al. A novel CDKL5 mutation in a 47,XXY boy with the early-onset seizure variant of Rett syndrome. Am J Med Genet A 2009;149A:232-236.
19. Carouge D, Host L, Aunis D, et al. CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol Dis 2010;38:414-424.
20. Mari F, Azimonti S, Bertani I, et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 2005;14:1935-1946. (Pubitemid 41418030)
21. Le Meur N, Holder-Espinasse M, Jaillard S, et al. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. J Med Genet 2010;47:22-29.
22. Zweier M, GregorA, ZweierC, et al. Mutations in MEF2Cfrom the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retarda tion and diminish MECP2 and CDKL5 expression. Hum Mutat 2010;31:722-733.
23. Cardoso C, Boys A, Parrini E, et al. Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion. Neurology 2009;72:784-792.
24. Engels H, Wohlleber E, ZinkA, et al. A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients. Eur J Hum Genet 2009;17:1592-1599.
25. Benarroch E. Astrocyte-neuron interactions: implications for epilepsy. Neurology 2009;73:1323-1327.
26. Gomez-Gonzalo M, Losi G, Chiavegato A, et al. An excitatory loop with astrocytes contributes to drive neurons to seizure threshold. PLoS Biol 2010;8:e1000352.
27. David Y, Cacheaux LP, Ivens S, et al. Astrocytic dysfunction in epileptogen-esis: consequence of altered potassium and glutamate homeostasis? J Neurosci 2009;29:10588-10599.
28. Hagerman P, Stafstrom C. Origins of epilepsy in fragile X syndrome. Epilepsy Curr 2009;9:108-112.
29. Jacobs S, Doering LC. Astrocytes prevent abnormal neuronal development in the fragile X mouse. J Neurosci 2010;30:4508-4514.
30. Min WW, Yuskaitis CJ, Yan Q, et al. Elevated glycogen synthase kinase-3 activity in fragile X mice: key metabolic regulator with evidence for treatment potential. Neuropharmacology 2009;56:463-472.
31. Yuskaitis CJ, Beurel E, Jope RS. Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of fragile X syndrome. Biochim Biophys Acta 2010;1802:1006-1012.
32. Ballas N, Lioy DT, Grunseich C, Mandel G. Noncell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 2009;12:311-317.
33. Iyer AM, Zurolo E, Boer K, et al. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies. Neuroscience 2010;167:929-945.